Nailesh A. Bhatt has more than 20 years of pharmaceutical industry experience across the value chain working with start-ups to Fortune 500 companies.
Mr. Bhatt is the Founder and Managing Director of Proximare, a strategic advisory firm that develops and implements growth strategies, including strategy development, licensing, mergers, acquisitions and joint ventures. At Proximare, Mr. Bhatt works with a wide range of companies including large pharma, generics, private equity groups, CROs, CMOs, wholesalers, distributors, PBMs, payers, retailers, GPOs, and more. Proximare has successfully completed multiple M&A transactions, including cross-border deals. While at Proximare, Mr. Bhatt also launched Proximare Life Sciences Fund.
Prior to Proximare, Mr. Bhatt was the founder of BulkDrugs.com with presence in the U.S., India and Japan.
Before that, Mr. Bhatt worked in increasing roles and responsibilities at Arthur Andersen, Seppic, and Sidmak Laboratories.
From 2015 to 2017, Mr. Bhatt was an Advisor for commercialization strategy to the Board of Directors of OncoBiologics (NASDAQ: ONS).
Mr. Bhatt is a sought-after speaker at various industry conferences, and has also presented at the India Economic Summit organized by World Economic Forum, the Federal Trade Commission and more.
©2016 CutisPharma, Inc.
FI℞ST® and the FI℞ST® logo are registered
trademarks of CutisPharma, Inc.